Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.99 USD | +1.89% | -4.00% | +347.25% |
May. 08 | Wedbush Raises Janux Therapeutics' PT to $74 From $53, Keeps Outperform Rating | MT |
May. 08 | Janux Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 3.14M | Sales 2025 * | 2.04M | Capitalization | 2.49B |
---|---|---|---|---|---|
Net income 2024 * | -74M | Net income 2025 * | -97M | EV / Sales 2024 * | 792 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1,221 x |
P/E ratio 2024 * |
-35
x | P/E ratio 2025 * |
-28.4
x | Employees | 68 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.49% |
1 day | +1.89% | ||
1 week | -4.00% | ||
Current month | -15.81% | ||
1 month | -1.44% | ||
3 months | +381.83% | ||
6 months | +430.28% | ||
Current year | +347.25% |
Managers | Title | Age | Since |
---|---|---|---|
David Campbell
CEO | Chief Executive Officer | 65 | 17-05-31 |
Tighe Reardon
DFI | Director of Finance/CFO | 48 | 17-05-31 |
Jenna Daly
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Vickie Capps
BRD | Director/Board Member | 62 | 21-03-17 |
Jay Lichter
CHM | Chairman | 62 | 17-05-31 |
Director/Board Member | 68 | 21-09-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +11.21% | - | |
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 47.99 | +1.89% | 903,867 |
24-05-17 | 47.1 | -0.86% | 698,030 |
24-05-16 | 47.51 | +0.06% | 680,511 |
24-05-15 | 47.48 | -0.90% | 918,683 |
24-05-14 | 47.91 | -4.16% | 690,725 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+347.25% | 2.44B | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- JANX Stock